Rapport Therapeutics Newsroom

TD Cowen Maintains Rapport Therapeutics(RAPP.US) With Buy Rating

Futu NewsNov 8 01:31

Rapport Therapeutics, Inc. (RAPP) Gets a Buy From TD Cowen

TipRanksNov 8 01:05

Rapport Therapeutics Analyst Ratings

BenzingaOct 18 21:02

JonesTrading Initiates Rapport Therapeutics(RAPP.US) With Buy Rating, Announces Target Price $42

Futu NewsOct 18 05:32

Jefferies Maintains Rapport Therapeutics(RAPP.US) With Buy Rating, Maintains Target Price $35

Futu NewsOct 3 20:31

Buy Rating Affirmed for Rapport Therapeutics Amid Promising Phase IIa Epilepsy Study and RAP-219's Market Potential

TipRanksOct 3 20:19

TD Cowen Sticks to Their Buy Rating for Rapport Therapeutics, Inc. (RAPP)

TipRanksAug 9 02:28

Rapport Therapeutics Analyst Ratings

BenzingaJul 2 17:55

Buy Rating for Rapport Therapeutics: Disruptive CNS Treatments and Promising Drug Efficacy

TipRanksJul 2 17:03